Aerin Medical Inc. v. Neurent Medical Inc.
Patent Trial and Appeal Board
Holding
The Federal Circuit dismissed the appeals under Federal Rule of Appellate Procedure 42(b) by party agreement. Each side will bear its own costs.
Why It Matters
The order ends these PTAB appeals without any Federal Circuit merits ruling on the underlying IPR issues.
Full Summary
Key Points
- The appeals arose from six PTAB IPR proceedings involving Aerin Medical, The Foundry, and Neurent entities.
- The Federal Circuit did not address patentability, claim construction, or any other merits issue.
- Dismissal was entered under FRAP 42(b) based on the parties' agreement.
- The court ordered each side to bear its own costs and issued the order as the mandate the same day.
How this summary was made: Drafted with AI from the court's opinion or order. Read the document itself before relying on the summary. Editorial policy
New to District court litigation? Start with PTAB vs. District Court: Where to Challenge a Patent’s Validity
- ITC · Oct. 16, 2026Certain Storage Containers and Toolboxes, Organizers, Component Boxes, Coolers, and Accessories Used Therewith; Inv. No. 337-TA-1409 (Violation)
- Fed. Cir. · Oct. 14, 2026Syngenta Crop Protection AG v. UPL Ltd.
- Fed. Cir. · Oct. 6, 2026Inari Agriculture, Inc. v. Corteva Agriscience LLC
- Fed. Cir. · Oct. 5, 2026O'Reilly Winship LLC v. SnapRays LLC
- Fed. Cir. · Oct. 1, 2026Satius Holding, LLC v. Samsung Electronics Co., Ltd.
